What's happening
This bill allows pharmacists to order and administer additional FDA-approved tests, including RSV, strep, HbA1c, hepatitis C, and HIV, and extends the law’s duration from two to four years.
Why it matters
Expanding pharmacists’ authority to administer and order tests for RSV, strep, HbA1c, hepatitis C, and HIV could increase access to critical screening, especially in areas with limited healthcare providers. This may help with earlier detection and intervention for both infectious and chronic diseases.
Allowing pharmacists to conduct these additional FDA-authorized tests could help relieve pressure on other healthcare settings, such as doctors’ offices and urgent care centers, by offering more convenient testing options. This could lead to faster diagnosis and treatment for common illnesses and public health concerns.
Extending the duration of the law from two to four years provides a longer trial period to assess the impact, effectiveness, and safety of pharmacists’ expanded testing role. This may encourage more investment in pharmacy-based healthcare services and give policymakers more data for future decisions.
Enabling pharmacists to order and administer tests for HIV and hepatitis C could support public health goals around reducing the spread of these infections and improving linkage to care for underserved populations. This could be particularly significant in communities where stigma or access issues make traditional testing less accessible.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Licensed pharmacists
The bill would expand their authority to order and administer FDA-authorized tests to include RSV, Group A strep pharyngitis, HbA1c, hepatitis C and HIV, subject to federal laboratory waiver requirements.
Patients seeking testing
The bill would allow patients to obtain the newly listed tests from licensed pharmacists.
Limited service laboratories
The bill would extend the sunset on provisions allowing pharmacists to direct these laboratories and order and administer covered tests from two years to four years after the underlying law became law.
Nurse practitioners
The bill would also extend the sunset on provisions of the 2022 law addressing nurse practitioner practice from two years to four years after that law became law.
Headline styles
Pharmacists Can Give More Tests
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to higher education
- Delivered to assembly
- Passed senateVote 60–1
- Advanced to third reading
- 2nd report cal.
- 1st report cal.167
- Referred to health
- Print number 3467a
- Amend (t) and recommit to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Pharmacists Can Give More Tests
In Assembly Committee · Higher Education · Sponsor John T. McDonald III
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
3467--A
2023-2024 Regular Sessions
IN SENATE
January 31, 2023
Introduced by Sens. RIVERA, ADDABBO, GALLIVAN, GOUNARDES, KRUEGER, SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the education law, in relation to allowing a licensed pharmacist to order and administer certain tests; and to amend part C of chapter 57 of the laws of 2022 amending the public health law and the education law relating to allowing pharmacists to direct limited service laboratories and order and administer COVID-19 and influenza tests and modernizing nurse practitioners, in relation to the effectiveness thereof
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 7 of section 6801 of the education law, as added by section 2 of part C of chapter 57 of the laws of 2022, is amended to read as follows:
7. A licensed pharmacist is a qualified health care professional under section five hundred seventy-one of the public health law for the purposes of directing a limited service laboratory and ordering and administering COVID-19 [and], influenza, respiratory syncytial virus (RSV), pharyngitis resulting from a Group A streptococcal infection, HbA1c, hepatitis C, and human immunodeficiency virus (HIV) tests authorized by the Food and Drug Administration (FDA), subject to certificate of waiver requirements established pursuant to the federal clinical laboratory improvement act of nineteen hundred eighty-eight.
§ 2. Section 8 of part C of chapter 57 of the laws of 2022 amending the public health law and the education law relating to allowing pharmacists to direct limited service laboratories and order and administer COVID-19 and influenza tests and modernizing nurse practitioners, is amended to read as follows:
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD02558-07-3
§ 8. This act shall take effect immediately and shall be deemed to have been in full force and effect on and after April 1, 2022; provided, however, that sections one, two, three, four, six and seven of this act shall expire and be deemed repealed [two] four years after it shall have become a law.
§ 3. This act shall take effect immediately; provided, however, that the amendments to subdivision 7 of section 6801 of the education law made by section one of this act shall not affect the repeal of such subdivision and shall be deemed repealed therewith.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the education law, in relation to allowing a licensed pharmacist to order and administer certain tests; and to amend part C of chapter 57 of the laws of 2022 amending the public health law and the education law relating to allowing pharmacists to direct limited service laboratories and order and administer COVID-19 and influenza tests and modernizing nurse practitioners, in relation to the effectiveness there- of
Purpose
The purpose of this bill is to expand pharmacists' ability to perform tests for certain illnesses and conditions to also include respiratory syncytial virus (RSV), strep throat, HbA1c (blood sugar levels), hepati- tis C (Hep C), and human immunodeficiency virus (HIV).
Summary of provisions
Section 1 amends subdivision 7 of section 6801 of the Education Law, as it relates to the definition of the practice of pharmacy, to allow a licensed pharmacist to perform limited service laboratory and ordering and administering a test for respiratory syncytial virus (RSV), pharyn- gitis resulting from group A streptococcal infection (commonly referred to as strep throat), HbA1c (blood sugar levels), hepatitis C, and human immunodeficiency virus (HIV).
Currently under this section of law pharmacists are already authorized to initiate tests for COVID-19 and influenza.
Section 2 extends the effective date of the underlying section of law that authorizes pharmacists to order and administer tests by an addi- tional two years until April 1, 2026.
Section 3 establishes an effective date.
Justification
New York State is behind the rest of the country concerning the scope of practice for pharmacists and health care in general, especially when it comes to collaborative practice.
According to the National Association of the Boards of Pharmacy, 39 states currently permit pharmacists to Perform non-invasive FDA-approved tests, commonly described as Clinical Laboratory Improvement Amendments (CLIA)-waived tests. These are simple, low-risk tests available without a prescription or medical order. During the COVID-19 pandemic and beyond, pharmacists were a valuable community service provider for COVID testing and it makes sense to expand testing in a limited manner to other disease states such as RSV, strep throat, Hep C, and HIV for patient convenience. The bill would also allow a pharmacist to test HbA1c, a common test for blood sugar levels associated with diabetes.
Pharmacists are licensed clinicians uniquely situated to advance New York's public health objectives as they represent an opportunity to engage members of the public that otherwise might not be reached. Authorizing the Commissioner of Health to specify the tests that a phar- macist would perform limits the actual tests to be completed by pharma- cists and provides needed flexibility to respond to public health needs and programs.
This legislation can improve therapeutic outcomes and the quality of care overall. As mentioned, pharmacists are well-positioned to enhance the continuity of care connected to a patient's medical home.
Legislative history
2019-2020: S5092/A3867A McDonald - Advanced to Third Reading
2021-2022: S2529 Rivera/A3033 McDonald - Advanced to Third Reading
Fiscal implications
None.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.